SKF S 106203
Alternative Names: SKF 106203; SKF 106203 Z2Latest Information Update: 21 Jan 2008
At a glance
- Originator GlaxoSmithKline
- Developer GlaxoSmithKline; Nonindustrial source
- Class Antiallergics; Antiasthmatics
- Mechanism of Action Immunosuppressants; Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Kidney disorders; Transplant rejection
Most Recent Events
- 24 Jan 2001 SmithKline Beecham has merged with Glaxo Wellcome to form GlaxoSmithKline
- 31 Jul 2000 Preclinical development for Kidney disorders in USA (Unknown route)